Results 131 to 140 of about 4,278 (207)

Plasmapheresis for refractory toxic epidermal necrolysis unresponsive to conventional therapy: a case report and literature review. [PDF]

Front Immunol
Liao SQ, Yan ZR, Lin LW, Deng M, Xiao GJ, Gao PY.   +5 more
europepmc   +1 more source

An unusual case of central retinal vein occlusion, treated successfully with intravenous fibrinolysin.

, 1961
Morton Wr, William Turnbull
openalex   +1 more source

Invivo generated autologous plasmin enzyme assisted vitrectomy, partial circumferential-oral retinotomy, silicone oil injection in patients with chronic retinal detachment without posterior vitreous detachment. [PDF]

Graefes Arch Clin Exp Ophthalmol
Aras C, Senturk F, Erdur SK, Dogramaci M, Kocabora MS, Demircan A, Budak YE.   +6 more
europepmc   +1 more source

Fibrinolysinoma after direct injection of fibrinolysin for treatment of nasal tip swelling: a case report.

, 2012
Abdoljalil Kalantar Hormozi, Seyed Reza Rafei   +1 more
openalex   +1 more source

Debridement for surgical wounds. [PDF]

Cochrane Database Syst Rev
Smith F, Donaldson J, Brown T.
europepmc   +1 more source

Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer. [PDF]

BMC Biotechnol
Ji Y, Qin Y, Tan Q, Qiu Y, Han S, Qi X.
europepmc   +1 more source

Investigation and Management of a Small Outbreak of Septic Knee Arthritis Following Knee Arthroscopy by <i>Stenotrophomonas maltophilia</i>. [PDF]

J Med Cases
Yin L, Yang S, Liao DF, Yang WJ, Liu JB, Deng B.   +5 more
europepmc   +1 more source

The effect of fibrinolysin ointment in the treatment of burn scars: A narrative review article

Jafar Kazemzadeh
openalex   +2 more sources

Perioperative treatment with tranexamic acid in melanoma (PRIME): protocol for a Danish multicentre randomised controlled trial investigating the prognostic and treatment-related impact of the plasminogen-plasmin pathway. [PDF]

BMJ Open
Kristjansen KA, Engel Krag A, Schmidt H, Hölmich LR, Bønnelykke-Behrndtz ML.   +4 more
europepmc   +1 more source